FULLERTON, Calif., Dec. 16 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. , today announced that it has closed its offering of $600 million aggregate principal amount of 2.50% Convertible Senior Notes due 2036. The closing of the offering has satisfied one of the conditions of the tender offer.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO )
As previously announced, the tender offer and withdrawal rights will expire at 5:00 p.m., New York City time, on Tuesday, December 19, 2006, unless extended.
The complete terms and conditions of the offer are set forth in the Offer to Purchase, dated December 11, 2006 and related Letter of Transmittal which are available by contacting the Information Agent for the offer, Global Bondholder Services Corporation at (866) 294-2200. (toll free). Persons with questions regarding the offer should contact Morgan Stanley at (800) 624-1808 (toll free) or (212) 761-5746 (collect).
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum - from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing - Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world. The company, based in Fullerton, California, reported 2005 annual sales of $2.44 billion with 71.5 percent of this amount generated by recurring revenue from supplies, test kits, services and operating-type lease payments. For more information, visit http://www.beckmancoulter.com/
Contact: Robert Raynor (714) 773-7620
Director, Investor Relations
